ICF is a pioneering Brazilian bioequivalence and bioavailability laboratory that has made significant contributions to the pharmaceutical industry since its establishment in 2002. As the first laboratory in Brazil to receive certification from ANVISA, ICF is recognised as one of the largest pharmaceutical research centres in Brazil and Latin America. Its commitment to ethics and innovation ensures the credibility and quality of its products, making it a notable reference for industries and investors from various countries.

Services include:
- Biopharmaceuticals
- Contract Research
- Bioequivalence Studies
- Bioavailability Studies
- Specialty and Fine Chemical Intermediates
- Custom Manufacturing
- Natural Products

ICF plays a vital role in the development of generic drugs in Brazil, having conducted over 700 bioequivalence studies to date. For further details about ICF and its offerings, visit icf.com.br.